Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01838252

Hyaluronic Acid Gels for Lower Lid Retraction

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Lid retraction is a difficult problem encountered in oculofacial plastic surgery. It can result from previous surgery, radiotherapy or cicatrizing disease or it may be idiopathic. Whatever the aetiology, the cosmetic appearance is troublesome to patients and, can be damaging to the cornea. The definitive therapy for lid retraction is surgical, and often involves complicated procedures including tissue grafting. Hyaluronic acid gels (HAG) have been FDA approved for the treatment of facial rhytids by subcutaneous injection and volume addition. These gels have gained wide popularity in for cosmetic applications in filling volume deficit areas. Functional applications in the periorbital area have also been described including the filling of volume deficit anophthalmic orbits, ectropion and loagophthalmos. Additionally, pilot studies have found HAG to be useful in correcting both upper and lower eyelid retraction, with good effect. The purpose of this investigation is to define the clinical utility of HAG correction of lower eyelid retraction in terms of anatomic (lid position), quantitative (dry eye signs on cornea) and qualitative effects (symptom severity). Our hypothesis is that HAG correction of lower eyelid retraction will improve patient comfort, clinical signs of dry eye and aesthetic self image.

Conditions

Interventions

TypeNameDescription
PROCEDUREHyaluronic acidHyaluronic acid filler will be injected in to the lower lid, elevating it to a more anatomic position
PROCEDURESalineSaline will be injected in to the lower lid, elevating it to a more anatomic position

Timeline

Start date
2013-02-01
Primary completion
2014-02-01
Completion
2014-05-01
First posted
2013-04-24
Last updated
2014-12-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01838252. Inclusion in this directory is not an endorsement.